The pharmaceutical industry desperately needs to evolve in order to survive. Is open innovation the answer?
Why Johnson & Johnson’s Paul Stoffels believes greater differentiation and a move toward open innovation are the answer to the industry’s woes.
Fred Hassan opens up on what it takes to be an exceptional leader in the pharmaceutical industry.
Frost & Sullivan’s Sumit Sharma on the importance of emerging markets to the future success of the pharma industry.
The top 25 psychiatric drugs of 2009, according to quantities of US prescriptions, have been published and the chart reveals that approximately 300 million prescriptions were written for these 25 medications during 2009 alone. Clearly psychiatric drugs are a booming business.